Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Anabolic steroid users may face higher risk of severe COVID-19.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.